Artificial intelligence hype currently exceeding capability in medicine
Click Here to Manage Email Alerts
Artificial intelligence in medicine is currently in the infancy stage of development, but in 10 to 20 years, the capability of the technology will catch up to the hype, a speaker said at Octane’s virtual Ophthalmology Technology Summit.
“In the future, ophthalmologists will have to learn about AI, or you’ll be vulnerable to ophthalmologists who actually know AI,” keynote speaker Anthony Chang, MD, MBA, MPH, MS, chief intelligence and innovation officer at Children’s Hospital of Orange County, said at the meeting.
The essence of AI in medicine is moving away from evidence-based medicine to achieve precision medicine and population health. A huge information and knowledge gap must be made up by intelligence-based medicine rather than evidence-based medicine, Chang said.
“This is important when we think about precision medicine, when we have so many layers of information and data that need to be gathered to make the best decision for each individual patient,” he said.
Chang said evidence-based medicine is simply using “what’s above the surface,” and intelligence-based medicine is using everything above and below the surface.
Deep learning software developed by Google has already affected ophthalmology, as an algorithm developed by the company could accurately detect diabetic retinopathy in retinal fundus photographs as accurately as human ophthalmologists. Deep neural networks have also been developed to accurately predict retinopathy of prematurity diagnoses as accurately as human ophthalmologists, he said.
These forms of autonomous AI, which have little to no level of human involvement, will likely have a big impact on the field of ophthalmology, Chang said.
“Ophthalmology is already taking advantage of medical imaging capability of AI, but there are other areas we can certainly explore. Right now, we’re in the Wright brothers stage of using artificial intelligence, but in a decade or more, we’ll be in the space flight equivalent of using artificial intelligence,” he said.
Collapse
Chang A. Artificial intelligence in ophthalmology: Irrational hype or paradigm shift. Presented at: Octane’s Ophthalmology Technology Summit; Aug. 6-8, 2020 (virtual meeting).
Read more about
Click Here to Manage Email Alerts